Portage Biotech INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
SCHEDULE 13D/A: Major Shareholder James Mellon Boosts Stake in Portage Biotech Through Private Offering
James Mellon, a significant investor, has increased his beneficial ownership in Portage Biotech Inc. to 16.7% by acquiring an additional 121,951 ordinary shares in a private offering at $4.10 per share, providing operating capital to the company.
SCHEDULE 13D/A: Major Shareholder Gregory Bailey Boosts Stake in Portage Biotech, Providing Operating Capital
Gregory H. Bailey, a significant shareholder, increased his beneficial ownership in Portage Biotech Inc. to 30.7% through a private placement, providing operating capital to the company.